1 completed, 1 recruiting. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Dolutegravir Pill: new trials by email Literature Review of Dolutegravir Pill trials Research Report on Dolutegravir Pill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance Dolutegravir Pill, Darunavir+Ritonavir - HIV-1-infection | Phase 3 | Recruiting | University of Nairobi | 392 | 2025-09-01 | 2025-09-11 |
| ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence Maraviroc Pill, Dolutegravir Pill, Truvada Pill - HIV/AIDS | Phase 4 | Completed | University of North Carolina, Chapel Hill | 36 | 2017-06-28 | 2019-11-22 |
Acquired Immunodeficiency Syndrome (1)
University of Nairobi (1) · University of North Carolina, Chapel Hill (1)
Kenya (1) · Lesotho (1) · Mozambique (1) · Tanzania (1) · United States (1)
Angela DM Kashuba, BScPhmPharmD (1) · Loice A Ombajo, MMed, MSc (1)
PMID 31033629, PMID 40354181, PMID 41824511
R01AI122319 (1)